• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

物质使用障碍与精神疾病之间的共病现象。

Comorbidity between substance use disorders and psychiatric conditions.

作者信息

Schuckit Marc A

机构信息

VA San Diego Healthcare System, San Diego, CA, USA.

出版信息

Addiction. 2006 Sep;101 Suppl 1:76-88. doi: 10.1111/j.1360-0443.2006.01592.x.

DOI:10.1111/j.1360-0443.2006.01592.x
PMID:16930163
Abstract

AIM

To review information relevant to the question of whether substance-induced mental disorders exist and their implications.

DESIGN AND METHOD

This paper utilized a systematic review of manuscripts published in the English language since approximately 1970 dealing with comorbid psychiatric and substance use disorders.

FINDINGS

The results of any specific study depended on the definitions of comorbidity, the methods of operationalizing diagnostic criteria, the interview and protocol invoked several additional methodological issues. The results generally support the conclusion that substance use mental disorders exist, especially regarding stimulant or cannabinoid-induced psychoses, substance-induced mood disorders, as well as substance-induced anxiety conditions.

CONCLUSIONS

The material reviewed indicates that induced disorders are prevalent enough to contribute significantly to rates of comorbidity between substance use disorders and psychiatric conditions, and that their recognition has important treatment implications. The current literature review underscores the heterogeneous nature of comorbidity.

摘要

目的

回顾与物质所致精神障碍是否存在及其影响相关的信息。

设计与方法

本文对自1970年以来发表的英文手稿进行了系统综述,这些手稿涉及共病的精神障碍和物质使用障碍。

研究结果

任何特定研究的结果取决于共病的定义、诊断标准的操作方法、访谈和方案,还引发了其他几个方法学问题。结果总体上支持物质使用精神障碍存在的结论,特别是关于兴奋剂或大麻素所致精神病、物质所致心境障碍以及物质所致焦虑状态。

结论

所审查的资料表明,所致障碍普遍存在,足以对物质使用障碍和精神疾病之间的共病率产生重大影响,并且对其的认识具有重要的治疗意义。当前的文献综述强调了共病的异质性。

相似文献

1
Comorbidity between substance use disorders and psychiatric conditions.物质使用障碍与精神疾病之间的共病现象。
Addiction. 2006 Sep;101 Suppl 1:76-88. doi: 10.1111/j.1360-0443.2006.01592.x.
2
[Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].[精神分裂症与共病物质使用障碍的药物治疗。一项系统评价]
Nervenarzt. 2008 Jan;79(1):17-8, 20-2, 24-6 passim. doi: 10.1007/s00115-007-2310-4.
3
Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis.1990-2017 年社区和临床环境中精神分裂症谱系障碍共病物质使用的流行情况:系统评价和荟萃分析。
Drug Alcohol Depend. 2018 Oct 1;191:234-258. doi: 10.1016/j.drugalcdep.2018.07.011. Epub 2018 Aug 22.
4
Theoretical approaches to the engagement with patients in case-management programmes and assertive outreach teams: A systematic review of the literature.以病例管理计划和积极外展团队为背景下与患者互动的理论方法:文献的系统综述。
J Psychiatr Ment Health Nurs. 2022 Oct;29(5):647-658. doi: 10.1111/jpm.12831. Epub 2022 Apr 24.
5
The use of Open Dialogue in Trauma Informed Care services for mental health consumers and their family networks: A scoping review.创伤知情护理服务中使用开放对话模式为心理健康消费者及其家庭网络提供服务:范围综述。
J Psychiatr Ment Health Nurs. 2024 Aug;31(4):681-698. doi: 10.1111/jpm.13023. Epub 2024 Jan 17.
6
Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.利培酮与其他抗精神病药物治疗重度精神疾病合并物质滥用患者的比较。
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011057. doi: 10.1002/14651858.CD011057.pub2.
7
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
8
The psychological burden associated with Ehlers-Danlos syndromes: a systematic review.Ehlers-Danlos 综合征相关的心理负担:系统评价。
J Osteopath Med. 2022 Apr 14;122(8):381-392. doi: 10.1515/jom-2021-0267.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Shared decision-making interventions for people with mental health conditions.心理健康问题患者的共同决策干预措施。
Cochrane Database Syst Rev. 2022 Nov 11;11(11):CD007297. doi: 10.1002/14651858.CD007297.pub3.

引用本文的文献

1
Fenofibrate treatment during withdrawal reverses symptoms of ethanol-induced depression in male rats.戒断期间使用非诺贝特治疗可逆转雄性大鼠乙醇诱导的抑郁症状。
Front Pharmacol. 2025 Aug 8;16:1626031. doi: 10.3389/fphar.2025.1626031. eCollection 2025.
2
Chronic Pain and Substance Use Disorders: A Brief Narrative Review of Genetic, Neurobiological, and Environmental Contributions to Comorbidity.慢性疼痛与物质使用障碍:关于遗传、神经生物学和环境因素对共病影响的简要叙述性综述
J Psychiatr Brain Sci. 2025;10(3). doi: 10.20900/jpbs.20250003. Epub 2025 Jun 10.
3
Cognitive Dysfunction in the Addictions (CDiA): protocol for a neuron-to-neighbourhood collaborative research program.
成瘾中的认知功能障碍(CDiA):一项从神经元到社区的合作研究计划方案
Front Psychiatry. 2025 May 19;16:1455968. doi: 10.3389/fpsyt.2025.1455968. eCollection 2025.
4
Evaluating the efficacy of valproic acid in alcohol use disorder: a systematic analysis of clinical trials from ClinicalTrials.gov.评估丙戊酸在酒精使用障碍中的疗效:来自ClinicalTrials.gov的临床试验系统分析。
Front Pharmacol. 2025 Apr 25;16:1503035. doi: 10.3389/fphar.2025.1503035. eCollection 2025.
5
Minority stress and stimulant use among US adult sexual minority men: A systematic review.美国成年性少数男性中的少数群体压力与兴奋剂使用:一项系统综述。
Drug Alcohol Depend Rep. 2025 Apr 12;15:100333. doi: 10.1016/j.dadr.2025.100333. eCollection 2025 Jun.
6
Substance-induced mental disorders and discontinuation of medication for opioid use disorder.物质所致精神障碍与阿片类物质使用障碍的药物停用
Drug Alcohol Depend. 2025 Jul 1;272:112685. doi: 10.1016/j.drugalcdep.2025.112685. Epub 2025 Apr 22.
7
Mental health conditions of young ethiopians who use substances: a cross-sectional study in West Arsi zone.使用毒品的埃塞俄比亚年轻人的心理健康状况:在西阿尔西地区的一项横断面研究。
BMC Psychiatry. 2025 Feb 19;25(1):151. doi: 10.1186/s12888-025-06550-8.
8
The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications.大麻合法化时代合成大麻素受体激动剂作为掺假物的再度出现:既往流行事件的教训及临床意义
Neurosci Biobehav Rev. 2025 Mar;170:106043. doi: 10.1016/j.neubiorev.2025.106043. Epub 2025 Feb 6.
9
Patterns of depression symptoms in relation to stressors and social behaviors during the COVID-19 pandemic among older youth and emerging adults in the United States.美国青少年和刚成年的年轻人在新冠疫情期间与压力源及社交行为相关的抑郁症状模式。
PLOS Glob Public Health. 2024 Oct 22;4(10):e0003545. doi: 10.1371/journal.pgph.0003545. eCollection 2024.
10
Cognitive Dysfunction in the Addictions (CDiA): A Neuron to Neighbourhood Collaborative Research Program on Executive Dysfunction and Functional Outcomes in Outpatients Seeking Treatment for Addiction.成瘾中的认知功能障碍(CDiA):一项关于执行功能障碍和寻求成瘾治疗的门诊患者功能结局的从神经元到社区的合作研究项目。
medRxiv. 2024 Oct 28:2024.08.30.24312806. doi: 10.1101/2024.08.30.24312806.